Psychiatric Times Vol 28 No 5

Black Psychiatrists of America Speak About Desmond Tutu

June 02, 2011

On behalf of the Black Psychiatrists of America, we are writing to the American Psychiatric Association regarding the recent “issues” that have been raised by some members of your association with respect to Archbishop Tutu being this year’s convocation speaker at your annual meeting in Hawaii in May.

The Vote on Tutu: Fair Hearing?

June 09, 2011

More details on the APA Assembly meeting in Washington discussing Desmond Tutu being designated as convocation speaker for the American Psychiatric Association’s recent annual meeting.

Recovery From Disability: Manual of Psychiatric Rehabilitation

June 09, 2011

Given Dr Liberman’s remarkable productivity and his amazing capacity to keep his finger on the pulse of the field, I expect to find practical guidance in such circumstances in the next edition of Recovery From Disability.

A Missed Opportunity

June 03, 2011

How accurate is this picture, and what explains the changing patterns of psychiatric practice? Gardiner Harris and The New York Times were near these important stories and missed them.

It’s Still Possible-Even in a Managed Care World

June 03, 2011

It is still possible for a psychiatrist to have a successful and very gratifying practice that provides psychotherapy (along with medication to those who need both)-even “in a managed care environment.”

A Psychiatrist’s Perspective on a Potentially Explosive Issue

June 03, 2011

Had the National Rifle Association (NRA) had its way and Bill 432 had been voted into law in Florida, physicians in that state would have been prohibited from asking their patients whether they have access to firearms.

Ethical Issues in Psychopharmacology

May 07, 2011

Excellence in psychopharmacology demands sensitivity to the associated ethical considerations. The key considerations of psychiatry are both complex and dynamic, and psychiatrists who develop and refine their ethics skill set will be in a better position to anticipate and respond to ethical dilemmas as they arise in their practice.

Volkswagen Psychopharmacology

June 02, 2011

We will have many medications in the future, he prophesied; that will not be a problem. Our challenge will be in teaching doctors how to use them, “otherwise it would be like giving a driver’s license to someone who can’t drive.”

What’s in It for Psychiatrists?

June 02, 2011

The challenge to learn enough relevant information about a patient in brief medication (and evaluative) sessions still exists. And there is also the challenge of picking a medication that will be acceptable and valued-both from a symbolic and biological standpoint.

The 2011 Psychiatric Times Ethics Survey: Moral Struggles

June 08, 2011

The goal of the survey was to go beyond ethical lessons, useful as these may be, and to learn how Psychiatric Times’ readers-who are on the front line of psychiatric practice-handle a series of hypothetical ethical scenarios.

Does MDMA Have a Role in Clinical Psychiatry?

May 07, 2011

Like every drug or technology that has therapeutic value, MDMA (3,4-methylenedioxymethamphetamine) has potential risks and benefits. Unlike most other drugs under clinical investigation, MDMA has a complex and controversial history that has delayed dispassionate scientific investigation into its therapeutic use.